However, there is lack of RCTs in T1D using the newest generation of GLP-1RA or dual GLP-1/GIP agonists, which are associated with significantly more weight loss
Interestingly, the plasma concentration achieved with once-weekly exenatide ER is comparable to that of a single injection of immediate-release exenatide (Byetta) [60, 61]
Going off a GLP-1 short for glucagon-like peptide-1 receptor agonist isnt without potential consequences
At the same time, gross spending increased ninefold, from about $1 billion in 2019 to almost $9 billion in 2024, and gross spending per GLP-1 prescription reached $1,000 in 2024
Utilization management tools are intended to balance cost control and access but may still pose barriers for people with a medical necessity to take these drugs
Comparative Metabolic Research: Retatrutide is increasingly used in comparative studies examining how triple-receptor agonism differs from dual-receptor and single-receptor approaches